Compare H1B visa sponsorship data between Asklepios Biopharmaceutical and Ernst & Young U.S.. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
9
Asklepios Biopharmaceutical
+100.0%
53,235
Ernst & Young U.S.
Median Salary
+68.9%
$250,000
Asklepios Biopharmaceutical
$148,000
Ernst & Young U.S.
Approval Rate
100.0%
Asklepios Biopharmaceutical
100.0%
Ernst & Young U.S.
Years Sponsoring
4
Asklepios Biopharmaceutical
+77.8%
18
Ernst & Young U.S.
Historical Trends
H1B Filings Over Time
Asklepios Biopharmaceutical
Ernst & Young U.S.
Median Salary Trend
Asklepios Biopharmaceutical
Ernst & Young U.S.
Where & What They Hire
Top H1B Job Categories
Asklepios Biopharmaceutical
Regulatory Affairs Managers 1 filings
Compliance Managers 1 filings
Molecular and Cellular Biologists 1 filings
Ernst & Young U.S.
Accountants and Auditors 580 filings
Database Administrators 449 filings
Software Developers 273 filings
Computer and Information Systems Managers 254 filings
Financial and Investment Analysts 185 filings
Top H1B Work Locations
Asklepios Biopharmaceutical
Acton, MA 2 filings
Research Triangle Park, NC 1 filings
Ernst & Young U.S.
New York, NY 275 filings
Chicago, IL 149 filings
San Francisco, CA 98 filings
Hoboken, NJ 97 filings
Dallas, TX 83 filings
Year-by-Year Breakdown
| Year | Asklepios Biopharmaceutical | Ernst & Young U.S. | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | - | - | - | 2,264 | $148,000 | 100.0% |
| FY2024 | - | - | - | 1,379 | $166,114 | 99.6% |
| FY2023 | 3 | $250,000 | 100.0% | 1,447 | $152,685 | 100.0% |
| FY2022 | 2 | $110,000 | 100.0% | 1,856 | $150,000 | 100.0% |
| FY2021 | 2 | $106,388 | 100.0% | 1,244 | $125,000 | 99.9% |
| FY2020 | - | - | - | 766 | $117,000 | 100.0% |
| FY2019 | - | - | - | 8,806 | $115,000 | 99.3% |
| FY2018 | - | - | - | 6,961 | $112,528 | 99.2% |
| FY2017 | - | - | - | 6,140 | $97,400 | 98.5% |
| FY2016 | - | - | - | 5,338 | $90,000 | 99.0% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Asklepios Biopharmaceutical or Ernst & Young U.S.?
- Asklepios Biopharmaceutical pays higher H1B salaries with a median of $250,000 compared to Ernst & Young U.S.'s $148,000.
- Which company sponsors more H1B visas, Asklepios Biopharmaceutical or Ernst & Young U.S.?
- Ernst & Young U.S. has sponsored more H1B visas with 53,235 total filings compared to Asklepios Biopharmaceutical's 9.
- How do Asklepios Biopharmaceutical and Ernst & Young U.S. H1B approval rates compare?
- Asklepios Biopharmaceutical has a 100.0% H1B approval rate while Ernst & Young U.S. has 100.0%. Both companies have the same approval rate.